Wyss InstituteGenetics – Wyss Institute

Decoding inflammatory bowel disease – on a chip

Jessica Leff — Thu, 21 May 2026 09:30:43 +0000

By Benjamin Boettner (BOSTON) — Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn’s disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to a lack of understanding of what exactly causes the increased inflammation, fibrosis, and compromised intestinal barrier that underlie this…

Source

Materializing safe, on-demand living therapeutics

Jessica Leff — Thu, 14 May 2026 17:55:55 +0000

By Benjamin Boettner (BOSTON) — Patient recovery from many debilitating conditions and diseases could be sped up significantly and be more effective if drugs and therapeutic molecules were delivered right to where they are needed in the body, over the entire regenerative process, and in doses finely tuned to therapeutic needs. An intriguing way to achieve this is the use of implantable…

Source

Cure ALD – Behind the Research | Alex LeNail – Safer Gene Therapy

Jessica Leff — Mon, 20 Apr 2026 15:26:58 +0000

Learn about Wyss Postdoctoral Fellow Alex LeNail‘s background and how he plans to develop a safer gene therapy for ALD (adrenoleukodystrophy) patients. If successful, this could go to clinical trials and give families hope for a cure. This video series tells the story of the scientists behind the breakthroughs, and why community-driven fundraising is the engine behind their discoveries. …

Source

Toward autonomous self-organizing biological robots with a nervous system

Mariel Schoen — Mon, 16 Mar 2026 18:30:42 +0000

By Benjamin Boettner (BOSTON) — Biobots, whose growing line of variants started with Xenobots, are fascinating tiny self-powered living robots built exclusively using frog embryonic cells. Originally developed in the laboratories of Wyss Institute Associate Faculty member and Tufts University Professor Michael Levin, Ph.D. and his collaborators at University of Vermont…

Source

Wyss Institute appoints three new Associate Faculty members: Ahmad Khalil, Jarad Mason, and Ting Wu

Jessica Leff — Mon, 08 Dec 2025 14:50:20 +0000

By Jessica Leff The Wyss Institute is proud to welcome three new Associate Faculty members: Ahmad (Mo) Khalil, Ph.D., Jarad Mason, Ph.D., and Chao-ting (Ting) Wu, Ph.D. Each has a history of collaborating with the Institute’s researchers. Their diverse expertise and fresh perspectives will further strengthen the Wyss’ innovative and collaborative ecosystem and enable pioneering advances in…

Source

How federal funds fuel life-saving innovation

Jessica Leff — Thu, 20 Nov 2025 17:49:40 +0000

Source

George Church on Widespread Genomic Sequencing, Xenotransplantation, and Shepherding Change

Jessica Leff — Mon, 17 Nov 2025 20:46:55 +0000

In this interview, GenomeWeb speaks to Core Faculty member George Church, Ph.D., who is also a professor at Harvard Medical School and the Harvard-MIT Program in Health Sciences and Technology. A thinker, inventor, and collaborator extraordinaire, Church’s technologies and personality catalyzed the Human Genome Project, the Personal Genome Project, and more than 50 biotech startups…

Source

Highly Cited Researchers 2025 honors nine Wyss members

Jessica Leff — Mon, 17 Nov 2025 18:50:51 +0000

By Alexandra Jirstrand (BOSTON) – Clarivate Analytics announced its Highly Cited Researchers 2025 list, which honors the top 1% of researchers around the world whose papers have been cited the most over the last decade. Clarivate uses both quantitative and qualitative analyses to identify individuals who have demonstrated significant and broad influence in their chosen field(s) of research.

Source

Recapitulating egg and sperm development in the dish

Jessica Leff — Fri, 15 Aug 2025 17:55:46 +0000

By Benjamin Boettner (BOSTON) — More than one-sixth of adults around the world experience infertility in their lifetime. There is a high unmet need not only for increased access to affordable, high-quality fertility care for those in need but, importantly, also for new biomedical solutions that can address the root causes of infertility. Some of the earliest causes of infertility go back to…

Source

The Wyss Institute’s 2025-2026 Validation Projects

Jessica Leff — Thu, 14 Aug 2025 15:00:53 +0000

Throughout recent years, the Wyss’ Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick-starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are driven by multi-talented teams…

Source